![Kenneth Hoberman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Hoberman
Direttore operativo presso
STEMLINE THERAPEUTICS, INC.
Patrimonio netto: 12 M $ in data 31/05/2026
Profilo
Kenneth Hoberman is Vice Chairman at Lirum Therapeutics, Inc. since 2021.
Mr. Hoberman is Independent Director at TG Therapeutics, Inc. since 2014.
Mr. Hoberman is Independent Director at Nuvectis Pharma, Inc. since 2021.
Mr. Hoberman is Chief Operating Officer at Stemline Therapeutics, Inc. since 2013.
Mr. Hoberman was Vice President-Corporate & Business Development at Keryx Biopharmaceuticals, Inc. from 2004 to 2012.
Mr. Hoberman completed undergraduate studies at Boston University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/06/2026 | 279.653 ( 0,18% ) | 11 M $ | 31/05/2026 | |
| 11/06/2026 | 168.140 ( 0,63% ) | 2 M $ | 31/05/2026 |
Posizioni attive di Kenneth Hoberman
| Società | Posizione | Inizio |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Direttore operativo | 01/01/2013 |
| TG THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 15/12/2014 |
| NUVECTIS PHARMA, INC. | Direttore/Membro del Consiglio | 01/07/2021 |
| LIRUM THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/11/2021 |
Precedenti posizioni note di Kenneth Hoberman
| Società | Posizione | Fine |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Corporate Officer/Principal | 01/01/2012 |
Formazione di Kenneth Hoberman
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
31
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvectis Pharma, Inc.
 Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
Lirum Therapeutics, Inc.
 Lirum Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on the treatment of debilitating diseases | Health Technology |
